文献速递针灸推拿中医康复

针灸治疗坐骨神经痛的有效性与安全性:系统综述与Meta分析

The effectiveness and safety of acupuncture treatment on sciatica: A systematic review and meta-analysis.
PubMed 文献 · Complement Ther Med · 2022-08-17

该系统综述与Meta分析比较针灸与镇痛药治疗坐骨神经痛的效果、安全性和持久性,共纳入28项RCT(2707例)。针灸组总有效率显著更高(RR=1.20,95%CI 1.16–1.24,P<0.001),VAS评分显著降低(MD=-1.78,95%CI -2.44至-1.12,P<0.001),痛阈显著升高(MD=0.93,95%CI 0.64–1.22,P<0.001),不良反应和复发率更低。

要点

  • 针灸治疗坐骨神经痛的总有效率显著优于镇痛药(RR=1.20)。
  • 针灸组VAS评分较镇痛药组显著降低(MD=-1.78)。
  • 针灸组痛阈显著升高(MD=0.93),不良反应和复发率更低。

核心结论

  • 针灸治疗坐骨神经痛在有效性和安全性方面显著优于镇痛药。
  • 未来需设计严谨的研究以提高针灸疗效与安全性证据的可靠性。

研究设计与样本

  • 系统综述与Meta分析,遵循Cochrane干预系统综述手册6.2版。
  • 检索万方、韩国传统知识门户、PubMed和EBSCOhost四个数据库。
  • 共纳入28项RCT,涉及2707例参与者。
  • 主要结局为总有效率、VAS评分和痛阈,次要结局为不良反应和复发率。
  • 采用RoB 2工具评估纳入RCT的方法学质量。

主要发现

  • 28项RCT(2707例)的总有效率针灸组显著高于镇痛药组(RR[95%CI]=1.20[1.16,1.24],P<0.001)。
  • 7项RCT(589例)的VAS评分针灸组显著低于镇痛药组(MD[95%CI]=-1.78[-2.44,-1.12],P<0.001)。
  • 5项RCT(311例)的痛阈针灸组显著高于镇痛药组(MD[95%CI]=0.93[0.64,1.22],P<0.001)。
  • 纳入RCT中针灸组的不良反应和复发率低于镇痛药组。

关键数值与推荐

  • 总有效率采用风险比(RR)及95%CI和P值进行Meta分析。
  • VAS评分和痛阈采用均数差(MD)及95%CI和P值进行Meta分析。
  • 不良反应和复发率用于评估干预的安全性和持久性。

临床怎么用

  • 针灸可作为坐骨神经痛镇痛的替代或补充治疗选择。
  • 对长期使用镇痛药存在安全性顾虑的患者,可考虑针灸治疗。

局限性

  • 原文未报告纳入RCT的具体偏倚风险分布。
  • 原文未报告异质性检验结果。
  • 原文未报告发表偏倚评估结果。
  • 原文未报告各结局的GRADE证据质量分级。
  • 原文未报告针灸具体穴方、疗程等干预细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sciatica results from primary or secondary damage to the sciatic nerve in the lumbar or gluteal region. The first option for sciatica is analgesics, but their therapeutic effect and safety in long-term use are questionable. On the other hand, acupuncture has recently been recognized as a complementary and alternative medicine (CAM) to conventional medicine, and studies on its effectiveness and safety have been actively conducted. OBJECTIVE: To systematically compare acupuncture with analgesics in terms of effect, safety, and durability in the treatment of sciatica METHODS: This review was performed in accordance with Cochrane Handbook for Systematic Reviews of Interventions Version 6.2. Four databases were searched for this review: Wangfang, the Korean Traditional Knowledge Portal (KTKP), PubMed, and EBSCOhost. The primary outcome measures in the review were total effective rate (TER), visual analog scale (VAS) score and pain threshold, and the secondary ones were adverse effects (AEs) and relapse rates. Risk ratio (RR) for TER and mean difference (MD) for VAS score and pain threshold were used as statistics for the meta-analysis of effectiveness, along with associated 95 % confidence intervals (CIs) and P-values. AEs and relapse rates were used for the safety and durability of the interventions. Version 2 of the Cochrane risk-of-bias assessment tool for randomized trials (RoB 2) was used for the methodological quality of randomized controlled trials (RCTs) included in the review. RESULTS: The synthesized TER of 28 RCTs involving 2707 participants was significantly higher in the acupuncture group compared to the analgesic group (RR [95 % CI] = 1.20 [1.16, 1.24], P < 0.001). The synthesized VAS score of 7 RCTs involving 589 participants was significantly reduced in the acupuncture group compared to the analgesic group (MD [95 % CI] = - 1.78 [- 2.44, - 1.12], P < 0.001). In 5 RCTs involving 311 participants, the synthesized pain threshold was significantly elevated in the acupuncture group compared to the analgesic group (MD [95 % CI] = 0.93 [0.64, 1.22], P < 0.001). Additionally, adverse effects (AEs) and relapse rates of RCTs in the review were lower in the acupuncture group compared to the analgesic group. CONCLUSION: In this systematic review, acupuncture treatment was significantly effective and safe compared to analgesics in sciatica. In the future, studies with a rigorous study design are required to increase the validity of the effectiveness and safety of acupuncture treatment for sciatica.

来源:Complement Ther Med,查看原文。版权归原作者所有。

引用

  1. Han KH, Cho KH, Han C, et al. The effectiveness and safety of acupuncture treatment on sciatica: A systematic review and meta-analysis. Complement Ther Med. 2022. PMID: 35985442. doi:10.1016/j.ctim.2022.102872

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。